Innoviva Specialty Therapeutics, Inc., a subsidiary of Innoviva, Inc., is a biopharmaceutical company developing and delivering innovative therapies in critical care and infectious disease.  Our approved treatments are indicated for use in life-threatening circumstances for seriously ill patients, and our investigational therapies are in development for patients fighting drug-resistant pathogens.

Growing antimicrobial resistance to existing therapies represents an urgent threat to global public health, and is directly related to significant mortality rates and longer, more expensive hospital stays. We are proud to work with physicians, nurses, hospital pharmacists and administrators, and all who devote their time to caring for patients. 

Biotechnology

Health Care

Therapeutics

Innoviva Specialty Therapeutics, Inc.

Steve Basso

David Altarac

Marianne Zhen

Marcie Cain

The Critical Care Team at Innoviva Specialty Therapeutics, Inc. is dedicated to advancing and optimizing the delivery of innovative therapies for seriously ill patients in critical care settings. This team works closely with healthcare professionals, including physicians, nurses, and hospital pharmacists, to ensure the effective use of our treatments. They provide specialized support and education on antimicrobial resistance and advocate for the adoption of our therapies in hospital and institutional settings to improve patient outcomes.

Critical Care Team

Director Team

Clinical Operations & Development

Critical Care Team

About

Team members

Other teams at Innoviva Specialty Therapeutics, Inc.

Director Team

Clinical Operations & Development